Restoring the balance: immunotherapeutic combinations for autoimmune disease
about
Biomimetic and synthetic interfaces to tune immune responsesSolving the puzzle of autoimmunity: critical questionsDivergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226.T cells in the control of organ-specific autoimmunityImmune interventions to preserve β cell function in type 1 diabetesStrategies for clinical trials in type 1 diabetesCytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.Targeting memory T cells in type 1 diabetes.Expansion of FasL-Expressing CD5+ B Cells in Type 1 Diabetes Patients.The immune system's role in sepsis progression, resolution, and long-term outcome.Challenges for the pharmaceutical technical development of protein coformulations.Colonic perforation in a patient with systemic lupus erythematosus accompanied by cytomegalovirus infection: A case report.Proceedings: Immune Tolerance and Stem Cell Transplantation: A CIRM Mini-Symposium and Workshop Report.From bench to patient: model systems in drug discoveryReceptor occupancy by flow cytometry.The anti-CD6 antibody itolizumab provides clinical benefit without lymphopenia in rheumatoid arthritis patients: results from a 6-month, open-label Phase I clinical trial.Colonic perforation due to severe cytomegalovirus disease in granulomatosis with polyangiitis after immunosuppression.CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms.Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patientsPredicting T cell recognition of MHC class I restricted neoepitopes
P2860
Q26801229-06AC253C-EB07-4284-93FD-137FFAB26CE6Q28084677-4E34058E-DFE2-49D9-BC9B-36B4B87CDBF1Q35762695-E52FB926-015F-467D-8C5B-37DF8DBD21A8Q35836118-57F02C9F-DBE0-4141-A852-F9103EDDC4CBQ36520618-BA73B885-6400-4F4A-9DFC-0246D3080AFEQ36995370-CB88CB71-AA1A-466A-9E18-7C7ED4F1E14EQ38244567-2456C624-809B-453F-86F2-1CC35B899821Q38586890-37D9F372-2948-4B92-926D-EFC6B696ED25Q38691330-0A4A0BD4-7A57-43EC-9016-6C47CD00705BQ38991057-72093D38-E54B-4042-8FDC-B4A9766B702EQ39282825-00EE25E7-BB9B-4F3E-B2DB-0DA5AAD99DCCQ40109239-584F268F-67C3-4B9D-BF2A-7CA4B774BA27Q42552506-1E6534D4-A588-4811-9613-A9F8E1EC5728Q42593469-4616A7CC-74E4-4ABA-8312-54D2FE96744CQ45030349-890A6236-6994-4042-8DCC-2A62B28A524BQ48265755-7C22C87D-DCE5-442C-8735-43A0E8972009Q48305722-AFD3963F-4948-4667-A93A-78A01252F027Q49788177-2517BB5A-A83A-4F78-9895-52B4820FF6B6Q57221897-456C1F0E-53FD-421B-8180-96D65C6F1340Q58129532-47038A23-2E58-491F-AEC9-82D76F530FF4
P2860
Restoring the balance: immunotherapeutic combinations for autoimmune disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Restoring the balance: immunotherapeutic combinations for autoimmune disease
@ast
Restoring the balance: immunotherapeutic combinations for autoimmune disease
@en
Restoring the balance: immunotherapeutic combinations for autoimmune disease.
@nl
type
label
Restoring the balance: immunotherapeutic combinations for autoimmune disease
@ast
Restoring the balance: immunotherapeutic combinations for autoimmune disease
@en
Restoring the balance: immunotherapeutic combinations for autoimmune disease.
@nl
prefLabel
Restoring the balance: immunotherapeutic combinations for autoimmune disease
@ast
Restoring the balance: immunotherapeutic combinations for autoimmune disease
@en
Restoring the balance: immunotherapeutic combinations for autoimmune disease.
@nl
P2860
P356
P1476
Restoring the balance: immunotherapeutic combinations for autoimmune disease
@en
P2093
Dawn E Smilek
Mario R Ehlers
P2860
P304
P356
10.1242/DMM.015099
P5008
P577
2014-05-01T00:00:00Z